For over three decades, the Division of Thoracic Surgery has demonstrated a proud tradition of pursuing innovative clinical and basic science research. Highlights of our research endeavors include:

  • There has been an evolving divisional focus and expertise on the monitoring of thoracic surgical outcomes using standardized prospective documentation of the incidence and severity of adverse events after thoracic surgery.
  • Leading in multi-center randomized controlled trials, such as the role of PET scanning in the management of lung cancer patients, the role of melatonin in decreasing lung cancer recurrence after resection, and the use of digital pleural drainage technology in the management of patients who had lung surgery.
  • We are developing an electronic system to perform bedside iPad clinical documentation, information management and quality monitoring
  • Minimal Invasive Surgery for Gastroesophageal Junction: this is a single center investigator driven clinical study to evaluate the short and long term impact of a fairly new Post-Approved surgical technique called minimally invasive “keyhole” surgery for Achalasia, Paraesophageal Hernia, GERD, and Zenkers Diverticulum disorders of the gastroesophageal junction. The expected study duration is 15-20 years. Although not mandatory, patients are suggested to be enrolled on their first visit after surgery. This study is actively recruiting patients.
  • Thoracic Morbidity and Mortality Classification ( this is a single center investigator driven Observational Study for Quality Assurance with a possibility to go multi center in near future. The Division of Thoracic Surgery has pioneered a classification system for objective grading of post-surgical complications for surgical quality improvement. The TM&M Database includes Thoracic Surgical volume and post-surgical complications since January 2008. TM&M has since been evaluated for its reliability and reproducibility. TM&M Data routinely serves as a source and analyzed to help with many other research studies. In its 3rd year, we are still actively enrolling all thoracic surgical patients.
Back to top